RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.534
https://www.valueinhealthjournal.com/article/S1098-3015(12)02247-4/fulltext
Title :
RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02247-4&doi=10.1016/j.jval.2012.08.534
First page :
A287
Section Title :
Drivers of Reimbursement Technology
Open access? :
No
Section Order :
54